Chemo-Free Triplet Yields 68% Response Rate in... - CLL Support
Chemo-Free Triplet Yields 68% Response Rate in most common CLL/SLL to Richter Transformation variant, diffuse large B-cell lymphoma (DLBCL)
You need to be a member of this community to see this post.
Read more about...
1 Reply
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
BRUIN Study: phase 1/2 study of Pirtobrutinib (formerly Loxo 305) in relapsed or refractory B-cell malignancies
Patients discontinue BTKi's due to resistance and intolerance. We evaluated the safety and efficacy...
Richter's and Novel Treatments/Combinations
We've had a few members post about Richter's recently so I thought it might be time for a bit of an...
Clinical Utility of Chromosomal Microarray in Richter's Transformation
Chromosomal microarray (CMA) is clever, very sensitive technology which looks for extra...
Advances in Targeted Therapy for R/R CLL OncLive videos & transcripts by Nirav Shah MD & Nicole Lamanna MD
Advances in Targeted Therapy for R/R CLL
(These OncLive presentations are intended for medical...
Richter's Syndrome! One pill, Triple Combination Therapy is in clinical trial for Richter’s Transformation & De Novo Large B-Cell Lymphoma
Richter's Syndrome! One pill, Triple Combination Therapy is in clinical trial for Richter’s...
Related Posts
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'- Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success- Chronic lymphocytic leukemia treatment algorithm 2022
- Real-World Study Shows Limited Implementation of Reccomended Biomarker Testing in CLL
